Takeda Pharmaceutical Limited
TAK | NYSE
$18.98
+$0.09 (+0.48%)
Sep 22, 2026, 1:29 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Mar 30, 2026 | FY 2024 Mar 30, 2025 | FY 2023 Mar 30, 2024 | FY 2022 Mar 30, 2023 | FY 2021 Mar 30, 2022 | FY 2020 Mar 30, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | 45.99 | 65.25 | 45.02 | 21.41 | 23.68 | 16.79 |
PEG Ratio | 0.53 | -2.53 | -0.82 | 0.55 | -0.61 | 0.02 |
PS Ratio | 1.94 | 1.56 | 1.52 | 1.69 | 1.53 | 1.97 |
PB Ratio | 1.19 | 1.03 | 0.89 | 1.07 | 0.96 | 1.22 |
P/FCF Ratio | 11.45 | 8.36 | 27.53 | 19.77 | 5.81 | 8.15 |
P/OCF Ratio | 9.30 | 6.77 | 9.05 | 6.95 | 4.85 | 6.25 |
OCF/S Ratio | 20.83 | 23.07 | 16.80 | 24.26 | 31.47 | 31.61 |
Debt / Equity Ratio | 0.63 | 0.65 | 0.67 | 0.69 | 0.76 | 0.90 |
Quick Ratio | 0.70 | 0.52 | 0.58 | 0.57 | 0.81 | 1.10 |
Current Ratio | 1.27 | 1.01 | 1.11 | 0.97 | 1.21 | 1.53 |
Asset Turnover | 0.31 | 0.32 | 0.28 | 0.29 | 0.27 | 0.25 |
Interest Coverage | 1.51 | 2.49 | 201.49 | 4.19 | 3.76 | 3.89 |
Return on Equity | 2.60% | 1.56% | 1.98% | 4.99% | 4.05% | 7.27% |
Return on Assets | 1.31% | 0.76% | 0.95% | 2.27% | 1.75% | 2.91% |
Return on Invested Capital | 3.11% | 1.72% | 1.63% | 3.51% | 3.12% | 4.56% |
Dividend Yield | 3.57% | 4.23% | 4.43% | 4.12% | 5.21% | 4.49% |
Payout Ratio | 162.65% | 280.28% | 199.34% | 88.14% | 123.30% | 75.36% |
FCF Payout Ratio | 56.30% | 50.03% | 174.32% | 98.81% | 31.74% | 38.46% |
Gross Profit Margin | 51.06% | 65.51% | 66.43% | 69.11% | 68.99% | 68.91% |
Net Profit Margin | 4.26% | 2.36% | 3.38% | 7.87% | 6.45% | 11.76% |
Pretax Profit Margin | 5.77% | 3.82% | 1.24% | 9.31% | 8.48% | 11.45% |
Operating Profit Margin | 11.99% | 7.48% | 5.02% | 12.18% | 12.91% | 15.93% |
FCF Margin | 13.12% | 14.79% | 5.53% | 8.53% | 26.26% | 24.22% |
EBITDA Margin | 29.72% | 26.42% | 26.83% | 31.88% | 33.15% | 30.76% |
Add to Watchlist
Select watchlists to add or remove TAK